Ideas to Action:

Independent research for global prosperity

Multimedia

CGD's weekly Global Prosperity Wonkcast, event videos, whiteboard talks, slides, and more.

The Race Against Drug Resistance (event video and audio)

The world is rapidly losing the ability to fight disease because of an invisible adversary: drug resistance. Resistance is inevitable but human actions are hastening it. Without a global effort to ensure lasting effectiveness of treatment, drug resistance is poised to get worse fast, raising costs, claiming more lives, and making future generations vulnerable to diseases that are easily cured today. After two years of study and analysis, CGD’s expert Drug Resistance Working Group urges four crucial steps to combat the problem in a pivotal new report, The Race Against Drug Resistance. On Tuesday, June 15, 2010 the Center for Global Development hosted the launch event of The Race Against Drug Resistance at the National Press Club.

Turning the Tide Through Better Prevention: Mead Over on the AIDS Transition

Mead OverEven as the cost of treating HIV/AIDS has fallen dramatically, the number of people newly infected has remained high. What can be done to reverse this trend and finally defeat this disease? This week on the Wonkcast, I’m joined by Mead Over, a senior fellow here at the Center for Global Development and perhaps the world’s leading expert on the economics of HIV/AIDS. He has recently published two major essays, which introduce the concept of the “AIDS transition”—the point in time where the number of people living with the disease begins to fall. He argues persuasively that to reach this point, international donors must greatly strengthen incentives for effective prevention.

“We should be very proud of the accomplishment in bringing down the numbers of AIDS deaths,” says Mead. “But the number of new infections… has not fallen enough. And so the result is we have a new take-off in the numbers of people living with AIDS.” Since 1997, he says, the number of HIV-infected people has increased by 50%, rising from around 22 million in 1997 to 33 million today.

Interviews with African HIV/AIDS Researchers

The Center for Global Development's HIV/AIDS Monitor staff works with local researchers in three African countries -- Mozambique, Uganda and Zambia - to jointly plan the key research questions and

Video from the XVII International AIDS Conference

As part of the XVII International AIDS Conference in Mexico City, the Center for Global Development addressed these issues in a two-part panel discussion on How are HIV/AIDS donors interacting with

The Private Sector And Global Health: Interview with April Harding (Video)

In this video, CGD visiting fellow April Harding describes the private sector's success in supporting health initiatives in developing countries. Harding provides an example of maternal care in India where government vouchers for private doctors provided the additional human resources to lower rates of maternal mortality.

Harding lead a CGD working group to identify how the private sector could support the health goals of the public sector. The working group recommended that donors create a private sector advisory facility that would provide on-demand support to policymakers in developing countries. So far, five donors have agreed to support this facility.

Beyond Gender as Usual (slidecast)

At a recent launch event for a new report Beyond Gender as Usual: How HIV/AIDS Donors Can Do More for Women and Girls released by the Center for Global Development and the International Center for Research on Women, director of CGD's HIV/AIDS Monitor Nandini Oomman and HIV/AIDS scientist Kim Ashburn's present thier findings.

What Are Donors Doing with AIDS Money? (Event)

Center for Global Development senior program associate and director of the HIV/AIDS Monitor Nandini Oomman discusses HIV/AIDS funding by the world's largest AIDS funders – PEPFAR, the Global Fund, and the World Bank.

HIV/AIDS Monitor (Interview)

In this video, CGD senior program associate and director of the HIV/AIDS Monitor Nandini Oomman describes her recent finding from the Seizing the Opportunity on AIDS and Health Systems report and outline Monitors future goals.

Pages